To Booster or Not: Scientists and Regulators Debate
To Booster or Not: Scientists and Regulators Debate
President Biden’s planned rollout of additional COVID-19 vaccine doses is set to begin next week, but questions remain about who should get them.
To Booster or Not: Scientists and Regulators Debate
To Booster or Not: Scientists and Regulators Debate

President Biden’s planned rollout of additional COVID-19 vaccine doses is set to begin next week, but questions remain about who should get them.

President Biden’s planned rollout of additional COVID-19 vaccine doses is set to begin next week, but questions remain about who should get them.

regulation
Biogen Defends Newly Approved Alzheimer’s Drug
Biogen Defends Newly Approved Alzheimer’s Drug
Jef Akst | Jul 27, 2021
The US Food and Drug Administration has called for a federal investigation of its own regulatory review process after widespread criticism of its decision on Aduhelm.
Human Stem Cell Research Guidelines Updated
Human Stem Cell Research Guidelines Updated
Ruth Williams | May 26, 2021
Removal of the 14-day limit for culturing human embryos is one of the main changes in the revised recommendations from the International Society for Stem Cell Research.
DEA Moves Toward Approving More Research Marijuana Growers
DEA Moves Toward Approving More Research Marijuana Growers
Shawna Williams | May 19, 2021
A regulatory change initiated during the Obama administration appears set to be put into practice, allowing more than one supplier of cannabis research products.
Pain Researcher Quits Academia, Takes Lab Home with Him
Pain Researcher Quits Academia, Takes Lab Home with Him
Jef Akst | May 1, 2021
After resigning from the University of New England last year, Geoffrey Bove continues to study the effects of massage on rats in a facility he set up in his house.
Pandemic Accelerates Trend Toward Remote Clinical Trials
Pandemic Accelerates Trend Toward Remote Clinical Trials
Jef Akst | May 1, 2021
Now more than ever before, recruiting patients for a research study doesn’t have to mean getting them to leave their homes.
Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA
Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA
Catherine Offord | Apr 8, 2021
The European Medicines Agency emphasizes that the benefits of the jab in protecting against COVID-19 still far outweigh the risks.
Science with Borders: Researchers Navigate Red Tape
Science with Borders: Researchers Navigate Red Tape
Max Kozlov | Mar 1, 2021
Scientists who work with foreign biological specimens face a patchwork of permits that threaten to block their projects, with potentially harmful consequences for the ecosystems they study.
A Federal Judge Ditches EPA’s Science Transparency Rule
A Federal Judge Ditches EPA’s Science Transparency Rule
Asher Jones | Feb 8, 2021
The Trump-era regulation, which allowed certain studies to be downplayed in the development of environmental regulations, drew sharp criticism from scientists and environmental groups.
Opinion: Europe Is Sinking Biotech—Again
Opinion: Europe Is Sinking Biotech—Again
Robert Paarlberg | Feb 1, 2021
Scientifically groundless regulations could undercut the potential of gene-edited crops, much as they have with GMOs.
Opinion: Emergency Use Authorizations Are a Threat to Science<strong>&nbsp;</strong>
Opinion: Emergency Use Authorizations Are a Threat to Science 
Kevin J. Tracey, Christina Brennan | Dec 1, 2020
As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
Jef Akst | Oct 8, 2020
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.
Panel Lays Out Guidelines for CRISPR-Edited Human Embryos
Panel Lays Out Guidelines for CRISPR-Edited Human Embryos
Lisa Winter | Sep 4, 2020
The International Commission on the Clinical Use of Human Germline Genome Editing claims the technology is still too risky for therapeutic use.
Variation in Cannabis Testing Challenges a Young Industry
Variation in Cannabis Testing Challenges a Young Industry
Katarina Zimmer | Mar 1, 2020
The US lacks standardized methods to assess products for potency and safety. That’s a big problem for the labs tasked with doing the testing.
Judge Rules Unreported Clinical Trial Data Must Be Made Public
Judge Rules Unreported Clinical Trial Data Must Be Made Public
Amy Schleunes | Feb 26, 2020
The sponsors of upwards of 1,000 clinical trials may be forced to publish data that have gone unpublished over a 10-year period.
EPA Science Board Criticizes Proposed Regulatory Rollbacks
EPA Science Board Criticizes Proposed Regulatory Rollbacks
Emily Makowski | Jan 3, 2020
Most of the panel’s members were appointed by the Trump administration.
Former FDA Commissioner Frank Young Dies
Former FDA Commissioner Frank Young Dies
Jef Akst | Dec 2, 2019
The physician-researcher laid the groundwork for genetic cloning and led the US Food and Drug Administration as the country faced the AIDS crisis in the 1980s.
Ebola Vaccine Approved for Use in Europe
Ebola Vaccine Approved for Use in Europe
Jef Akst | Nov 11, 2019
Merck’s Ervebo gets its first regulatory greenlight. A decision from the US Food and Drug Administration is expected in the next few months.
New Woes for MIT Media Lab
New Woes for MIT Media Lab
Ashley Yeager | Sep 24, 2019
Researchers say the Open Agricultural Initiative promoted a high-profile project with misleading claims, and documents show it violated state environmental regulations.
Trump Administration Overturns Clean Water Regulation
Trump Administration Overturns Clean Water Regulation
Emily Makowski | Sep 16, 2019
The repeal will return the US to water standards from 1986.